Celldex Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 40 U.S.-traded ETFs. CLDX has around 4.0M shares in the U.S. ETF market. The largest ETF holder of CLDX is the SPDR S&P Biotech ETF (XBI), with approximately 1.40M shares. Investors may also find of interest that the ETF with the largest allocation to CLDX stock is Invesco DWA SmallCap Momentum ETF (DWAS), with a portfolio weight of 2.33%. On average, U.S. ETFs allocate 0.26% of CLDX to their portfolios.
Additionally, CLDX is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CLDX as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.